Bluebird’s gene therapy halts progression of ‘devastating’ disease … – FierceBiotech
FierceBiotech |
Bluebird's gene therapy halts progression of 'devastating' disease …
FierceBiotech A single dose of Bluebird Bio's gene therapy for cerebral adrenoleukodystrophy (cALD) stabilized the disease in 15 of 17 patients over more than two years of … Gene therapy halts progression of cerebral adrenoleukodystrophy in … NEJM Publishes Interim Data from Study of Gene Therapy in Lorenzo bluebird bio (BLUE): Interim Results Preview A Significant Catalyst … |
